神経障害性疼痛治療のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Neuropathy Pain Treatment Market Insights and Forecast to 2028

• レポートコード：QY2203B11217 • 出版社/出版日：QYResearch / 2022年3月 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の神経障害性疼痛治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に神経障害性疼痛治療の世界市場のxxx％を占める「カルシウムチャネルα2δリガンド」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「小売薬局」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の神経障害性疼痛治療の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの神経障害性疼痛治療市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの神経障害性疼痛治療市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 神経障害性疼痛治療のグローバル主要メーカーには、Pfizer、Depomed、Eli Lilly、Endo、Grünenthal Group、Arbor Pharmaceuticalsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 神経障害性疼痛治療市場は、種類と用途によって区分されます。世界の神経障害性疼痛治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 カルシウムチャネルα2δリガンド、セロトニン・ノルエピネフリン再取込阻害剤、その他 【用途別セグメント】 小売薬局、病院、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 神経障害性疼痛治療製品概要 - 種類別市場（カルシウムチャネルα2δリガンド、セロトニン・ノルエピネフリン再取込阻害剤、その他） - 用途別市場（小売薬局、病院、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の神経障害性疼痛治療販売量予測2017-2028 - 世界の神経障害性疼痛治療売上予測2017-2028 - 神経障害性疼痛治療の地域別販売量 - 神経障害性疼痛治療の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別神経障害性疼痛治療販売量 - 主要メーカー別神経障害性疼痛治療売上 - 主要メーカー別神経障害性疼痛治療価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（カルシウムチャネルα2δリガンド、セロトニン・ノルエピネフリン再取込阻害剤、その他） - 神経障害性疼痛治療の種類別販売量 - 神経障害性疼痛治療の種類別売上 - 神経障害性疼痛治療の種類別価格 ・用途別市場規模（小売薬局、病院、その他） - 神経障害性疼痛治療の用途別販売量 - 神経障害性疼痛治療の用途別売上 - 神経障害性疼痛治療の用途別価格 ・北米市場 - 北米の神経障害性疼痛治療市場規模（種類別、用途別） - 主要国別の神経障害性疼痛治療市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの神経障害性疼痛治療市場規模（種類別、用途別） - 主要国別の神経障害性疼痛治療市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の神経障害性疼痛治療市場規模（種類別、用途別） - 主要国別の神経障害性疼痛治療市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の神経障害性疼痛治療市場規模（種類別、用途別） - 主要国別の神経障害性疼痛治療市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの神経障害性疼痛治療市場規模（種類別、用途別） - 主要国別の神経障害性疼痛治療市場規模（トルコ、サウジアラビア） ・企業情報 Pfizer、Depomed、Eli Lilly、Endo、Grünenthal Group、Arbor Pharmaceuticals ・産業チェーン及び販売チャネル分析 - 神経障害性疼痛治療の産業チェーン分析 - 神経障害性疼痛治療の原材料 - 神経障害性疼痛治療の生産プロセス - 神経障害性疼痛治療の販売及びマーケティング - 神経障害性疼痛治療の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 神経障害性疼痛治療の産業動向 - 神経障害性疼痛治療のマーケットドライバー - 神経障害性疼痛治療の課題 - 神経障害性疼痛治療の阻害要因 ・主な調査結果

This report studies the Neuropathy Pain Treatment market,
Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathy Pain Treatment is used for Neuropathic pain.
Market Analysis and Insights: Global Neuropathy Pain Treatment Market
The global Neuropathy Pain Treatment market size is projected to reach US$ 10730 million by 2028, from US$ 8527 million in 2021, at a CAGR of 3.3% during 2022-2028.
Global Neuropathy Pain Treatment key players include Eli Lilly, Pfizer, etc. Global top two manufacturers hold a share over 65%.
North America is the largest market, with a share about 45%, followed by Asia-Pacific and Europe, both have a share about 50 percent.
In terms of product, Calcium channel alpha 2-delta ligands is the largest segment, with a share about 70%. And in terms of application, the largest application is Retail Pharmacies, followed by Hospitals, etc.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Neuropathy Pain Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Neuropathy Pain Treatment market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Neuropathy Pain Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Neuropathy Pain Treatment market.
Global Neuropathy Pain Treatment Scope and Market Size
Neuropathy Pain Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Neuropathy Pain Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Calcium Channel Alpha 2-delta Ligands
Serotonin-norepinephrine Reuptake Inhibitors
Others
Segment by Application
Retail Pharmacies
Hospitals
Others
By Company
Pfizer
Depomed
Eli Lilly
Endo
Grünenthal Group
Arbor Pharmaceuticals
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

---

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuropathy Pain Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Calcium Channel Alpha 2-delta Ligands
1.2.3 Serotonin-norepinephrine Reuptake Inhibitors
1.2.4 Others
1.3 Market by Application
1.3.1 Global Neuropathy Pain Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Retail Pharmacies
1.3.3 Hospitals
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Neuropathy Pain Treatment Market Perspective (2017-2028)
2.2 Neuropathy Pain Treatment Growth Trends by Region
2.2.1 Neuropathy Pain Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Neuropathy Pain Treatment Historic Market Size by Region (2017-2022)
2.2.3 Neuropathy Pain Treatment Forecasted Market Size by Region (2023-2028)
2.3 Neuropathy Pain Treatment Market Dynamics
2.3.1 Neuropathy Pain Treatment Industry Trends
2.3.2 Neuropathy Pain Treatment Market Drivers
2.3.3 Neuropathy Pain Treatment Market Challenges
2.3.4 Neuropathy Pain Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neuropathy Pain Treatment Players by Revenue
3.1.1 Global Top Neuropathy Pain Treatment Players by Revenue (2017-2022)
3.1.2 Global Neuropathy Pain Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Neuropathy Pain Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neuropathy Pain Treatment Revenue
3.4 Global Neuropathy Pain Treatment Market Concentration Ratio
3.4.1 Global Neuropathy Pain Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuropathy Pain Treatment Revenue in 2021
3.5 Neuropathy Pain Treatment Key Players Head office and Area Served
3.6 Key Players Neuropathy Pain Treatment Product Solution and Service
3.7 Date of Enter into Neuropathy Pain Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neuropathy Pain Treatment Breakdown Data by Type
4.1 Global Neuropathy Pain Treatment Historic Market Size by Type (2017-2022)
4.2 Global Neuropathy Pain Treatment Forecasted Market Size by Type (2023-2028)
5 Neuropathy Pain Treatment Breakdown Data by Application
5.1 Global Neuropathy Pain Treatment Historic Market Size by Application (2017-2022)
5.2 Global Neuropathy Pain Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Neuropathy Pain Treatment Market Size (2017-2028)
6.2 North America Neuropathy Pain Treatment Market Size by Type
6.2.1 North America Neuropathy Pain Treatment Market Size by Type (2017-2022)
6.2.2 North America Neuropathy Pain Treatment Market Size by Type (2023-2028)
6.2.3 North America Neuropathy Pain Treatment Market Share by Type (2017-2028)
6.3 North America Neuropathy Pain Treatment Market Size by Application
6.3.1 North America Neuropathy Pain Treatment Market Size by Application (2017-2022)
6.3.2 North America Neuropathy Pain Treatment Market Size by Application (2023-2028)
6.3.3 North America Neuropathy Pain Treatment Market Share by Application (2017-2028)
6.4 North America Neuropathy Pain Treatment Market Size by Country
6.4.1 North America Neuropathy Pain Treatment Market Size by Country (2017-2022)
6.4.2 North America Neuropathy Pain Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Neuropathy Pain Treatment Market Size (2017-2028)
7.2 Europe Neuropathy Pain Treatment Market Size by Type
7.2.1 Europe Neuropathy Pain Treatment Market Size by Type (2017-2022)
7.2.2 Europe Neuropathy Pain Treatment Market Size by Type (2023-2028)
7.2.3 Europe Neuropathy Pain Treatment Market Share by Type (2017-2028)
7.3 Europe Neuropathy Pain Treatment Market Size by Application
7.3.1 Europe Neuropathy Pain Treatment Market Size by Application (2017-2022)
7.3.2 Europe Neuropathy Pain Treatment Market Size by Application (2023-2028)
7.3.3 Europe Neuropathy Pain Treatment Market Share by Application (2017-2028)
7.4 Europe Neuropathy Pain Treatment Market Size by Country
7.4.1 Europe Neuropathy Pain Treatment Market Size by Country (2017-2022)
7.4.2 Europe Neuropathy Pain Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neuropathy Pain Treatment Market Size (2017-2028)
8.2 Asia-Pacific Neuropathy Pain Treatment Market Size by Type
8.2.1 Asia-Pacific Neuropathy Pain Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Neuropathy Pain Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Neuropathy Pain Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Neuropathy Pain Treatment Market Size by Application
8.3.1 Asia-Pacific Neuropathy Pain Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Neuropathy Pain Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Neuropathy Pain Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Neuropathy Pain Treatment Market Size by Region
8.4.1 Asia-Pacific Neuropathy Pain Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Neuropathy Pain Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Neuropathy Pain Treatment Market Size (2017-2028)
9.2 Latin America Neuropathy Pain Treatment Market Size by Type
9.2.1 Latin America Neuropathy Pain Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Neuropathy Pain Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Neuropathy Pain Treatment Market Share by Type (2017-2028)
9.3 Latin America Neuropathy Pain Treatment Market Size by Application
9.3.1 Latin America Neuropathy Pain Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Neuropathy Pain Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Neuropathy Pain Treatment Market Share by Application (2017-2028)
9.4 Latin America Neuropathy Pain Treatment Market Size by Country
9.4.1 Latin America Neuropathy Pain Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Neuropathy Pain Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neuropathy Pain Treatment Market Size (2017-2028)
10.2 Middle East & Africa Neuropathy Pain Treatment Market Size by Type
10.2.1 Middle East & Africa Neuropathy Pain Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Neuropathy Pain Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Neuropathy Pain Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Neuropathy Pain Treatment Market Size by Application
10.3.1 Middle East & Africa Neuropathy Pain Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Neuropathy Pain Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Neuropathy Pain Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Neuropathy Pain Treatment Market Size by Country
10.4.1 Middle East & Africa Neuropathy Pain Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Neuropathy Pain Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Neuropathy Pain Treatment Introduction
11.1.4 Pfizer Revenue in Neuropathy Pain Treatment Business (2017-2022)
11.1.5 Pfizer Recent Developments
11.2 Depomed
11.2.1 Depomed Company Details
11.2.2 Depomed Business Overview
11.2.3 Depomed Neuropathy Pain Treatment Introduction
11.2.4 Depomed Revenue in Neuropathy Pain Treatment Business (2017-2022)
11.2.5 Depomed Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Neuropathy Pain Treatment Introduction
11.3.4 Eli Lilly Revenue in Neuropathy Pain Treatment Business (2017-2022)
11.3.5 Eli Lilly Recent Developments
11.4 Endo
11.4.1 Endo Company Details
11.4.2 Endo Business Overview
11.4.3 Endo Neuropathy Pain Treatment Introduction
11.4.4 Endo Revenue in Neuropathy Pain Treatment Business (2017-2022)
11.4.5 Endo Recent Developments
11.5 Grünenthal Group
11.5.1 Grünenthal Group Company Details
11.5.2 Grünenthal Group Business Overview
11.5.3 Grünenthal Group Neuropathy Pain Treatment Introduction
11.5.4 Grünenthal Group Revenue in Neuropathy Pain Treatment Business (2017-2022)
11.5.5 Grünenthal Group Recent Developments
11.6 Arbor Pharmaceuticals
11.6.1 Arbor Pharmaceuticals Company Details
11.6.2 Arbor Pharmaceuticals Business Overview
11.6.3 Arbor Pharmaceuticals Neuropathy Pain Treatment Introduction
11.6.4 Arbor Pharmaceuticals Revenue in Neuropathy Pain Treatment Business (2017-2022)
11.6.5 Arbor Pharmaceuticals Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Neuropathy Pain Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Calcium Channel Alpha 2-delta Ligands
Table 3. Key Players of Serotonin-norepinephrine Reuptake Inhibitors
Table 4. Key Players of Others
Table 5. Global Neuropathy Pain Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Neuropathy Pain Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Neuropathy Pain Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Neuropathy Pain Treatment Market Share by Region (2017-2022)
Table 9. Global Neuropathy Pain Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Neuropathy Pain Treatment Market Share by Region (2023-2028)
Table 11. Neuropathy Pain Treatment Market Trends
Table 12. Neuropathy Pain Treatment Market Drivers
Table 13. Neuropathy Pain Treatment Market Challenges
Table 14. Neuropathy Pain Treatment Market Restraints
Table 15. Global Neuropathy Pain Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Neuropathy Pain Treatment Revenue Share by Players (2017-2022)
Table 17. Global Top Neuropathy Pain Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuropathy Pain Treatment as of 2021)
Table 18. Ranking of Global Top Neuropathy Pain Treatment Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Neuropathy Pain Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Neuropathy Pain Treatment Product Solution and Service
Table 22. Date of Enter into Neuropathy Pain Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Neuropathy Pain Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Neuropathy Pain Treatment Revenue Market Share by Type (2017-2022)
Table 26. Global Neuropathy Pain Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Neuropathy Pain Treatment Revenue Market Share by Type (2023-2028)
Table 28. Global Neuropathy Pain Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Neuropathy Pain Treatment Revenue Share by Application (2017-2022)
Table 30. Global Neuropathy Pain Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Neuropathy Pain Treatment Revenue Share by Application (2023-2028)
Table 32. North America Neuropathy Pain Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Neuropathy Pain Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Neuropathy Pain Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Neuropathy Pain Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Neuropathy Pain Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Neuropathy Pain Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Neuropathy Pain Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Neuropathy Pain Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Neuropathy Pain Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Neuropathy Pain Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Neuropathy Pain Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Neuropathy Pain Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Neuropathy Pain Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Neuropathy Pain Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Neuropathy Pain Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Neuropathy Pain Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Neuropathy Pain Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Neuropathy Pain Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Neuropathy Pain Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Neuropathy Pain Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Neuropathy Pain Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Neuropathy Pain Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Neuropathy Pain Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Neuropathy Pain Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Neuropathy Pain Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Neuropathy Pain Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Neuropathy Pain Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Neuropathy Pain Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Neuropathy Pain Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Neuropathy Pain Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Neuropathy Pain Treatment Product
Table 65. Pfizer Revenue in Neuropathy Pain Treatment Business (2017-2022) & (US$ Million)
Table 66. Pfizer Recent Developments
Table 67. Depomed Company Details
Table 68. Depomed Business Overview
Table 69. Depomed Neuropathy Pain Treatment Product
Table 70. Depomed Revenue in Neuropathy Pain Treatment Business (2017-2022) & (US$ Million)
Table 71. Depomed Recent Developments
Table 72. Eli Lilly Company Details
Table 73. Eli Lilly Business Overview
Table 74. Eli Lilly Neuropathy Pain Treatment Product
Table 75. Eli Lilly Revenue in Neuropathy Pain Treatment Business (2017-2022) & (US$ Million)
Table 76. Eli Lilly Recent Developments
Table 77. Endo Company Details
Table 78. Endo Business Overview
Table 79. Endo Neuropathy Pain Treatment Product
Table 80. Endo Revenue in Neuropathy Pain Treatment Business (2017-2022) & (US$ Million)
Table 81. Endo Recent Developments
Table 82. Grünenthal Group Company Details
Table 83. Grünenthal Group Business Overview
Table 84. Grünenthal Group Neuropathy Pain Treatment Product
Table 85. Grünenthal Group Revenue in Neuropathy Pain Treatment Business (2017-2022) & (US$ Million)
Table 86. Grünenthal Group Recent Developments
Table 87. Arbor Pharmaceuticals Company Details
Table 88. Arbor Pharmaceuticals Business Overview
Table 89. Arbor Pharmaceuticals Neuropathy Pain Treatment Product
Table 90. Arbor Pharmaceuticals Revenue in Neuropathy Pain Treatment Business (2017-2022) & (US$ Million)
Table 91. Arbor Pharmaceuticals Recent Developments
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuropathy Pain Treatment Market Share by Type: 2021 VS 2028
Figure 2. Calcium Channel Alpha 2-delta Ligands Features
Figure 3. Serotonin-norepinephrine Reuptake Inhibitors Features
Figure 4. Others Features
Figure 5. Global Neuropathy Pain Treatment Market Share by Application: 2021 VS 2028
Figure 6. Retail Pharmacies Case Studies
Figure 7. Hospitals Case Studies
Figure 8. Others Case Studies
Figure 9. Neuropathy Pain Treatment Report Years Considered
Figure 10. Global Neuropathy Pain Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Neuropathy Pain Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Neuropathy Pain Treatment Market Share by Region: 2021 VS 2028
Figure 13. Global Neuropathy Pain Treatment Market Share by Players in 2021
Figure 14. Global Top Neuropathy Pain Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuropathy Pain Treatment as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Neuropathy Pain Treatment Revenue in 2021
Figure 16. North America Neuropathy Pain Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Neuropathy Pain Treatment Market Size Market Share by Type (2017-2028)
Figure 18. North America Neuropathy Pain Treatment Market Size Market Share by Application (2017-2028)
Figure 19. North America Neuropathy Pain Treatment Market Size Share by Country (2017-2028)
Figure 20. United States Neuropathy Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Neuropathy Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Neuropathy Pain Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Neuropathy Pain Treatment Market Size Market Share by Type (2017-2028)
Figure 24. Europe Neuropathy Pain Treatment Market Size Market Share by Application (2017-2028)
Figure 25. Europe Neuropathy Pain Treatment Market Size Share by Country (2017-2028)
Figure 26. Germany Neuropathy Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Neuropathy Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Neuropathy Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Neuropathy Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Neuropathy Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Neuropathy Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Neuropathy Pain Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Neuropathy Pain Treatment Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Neuropathy Pain Treatment Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Neuropathy Pain Treatment Market Size Share by Region (2017-2028)
Figure 36. China Neuropathy Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Neuropathy Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Neuropathy Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Neuropathy Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Neuropathy Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Neuropathy Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Latin America Neuropathy Pain Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Neuropathy Pain Treatment Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Neuropathy Pain Treatment Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Neuropathy Pain Treatment Market Size Share by Country (2017-2028)
Figure 46. Mexico Neuropathy Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Neuropathy Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Neuropathy Pain Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Neuropathy Pain Treatment Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Neuropathy Pain Treatment Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Neuropathy Pain Treatment Market Size Share by Country (2017-2028)
Figure 52. Turkey Neuropathy Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Neuropathy Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Neuropathy Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Pfizer Revenue Growth Rate in Neuropathy Pain Treatment Business (2017-2022)
Figure 56. Depomed Revenue Growth Rate in Neuropathy Pain Treatment Business (2017-2022)
Figure 57. Eli Lilly Revenue Growth Rate in Neuropathy Pain Treatment Business (2017-2022)
Figure 58. Endo Revenue Growth Rate in Neuropathy Pain Treatment Business (2017-2022)
Figure 59. Grünenthal Group Revenue Growth Rate in Neuropathy Pain Treatment Business (2017-2022)
Figure 60. Arbor Pharmaceuticals Revenue Growth Rate in Neuropathy Pain Treatment Business (2017-2022)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

---